When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PRVB - Provention Bio reaffirms PRV-031 application timeline; shares up 5% premarket
Provention Bio Inc.
Provention Bio (NASDAQ:PRVB) perks up 5% premarket on modest volume in reaction to its announcement that it continues to expect to start its rolling U.S. marketing application in mid-2020 for lead candidate PRV-031 (teplizumab) for the prevention or delay of type 1 diabetes (T1D) in at-risk people. The filing should be completed by Q4 2020.
More news on: Provention Bio, Inc., Healthcare stocks news, Stocks on the move,